In Europe, the Stoxx Europe 600 fell 0.3% in morning trading. Compass Group climbed 4.2% and Centrica rose 3.9%. On the other hand, Sartorius Stedim Biotech sank 7.1%, and Givaudan lost 6.7%. The FTSE ...

Trade, production, growth and other global economic vitals are proving resilient almost four months after President Trump's "Liberation Day" tariffs. The Reserve Bank of Australia's monetary policy ...

Lockheed Reports Earnings at a Tough Time. Drones and Defense Budgets Are a Worry. For the quarter, Wall Street is looking for earnings per share of about $6.41 from sales of $18.5 billion, according ...

Design software company Figma has set its tentative IPO pricing at $25-$28 per share, per a regulatory filing. This would ...

The Netherlands-based music conglomerate said it had filed a confidential registration statement with the Securities and Exchange Commission proposing the offering. AstraZeneca Plans to Invest $50 ...

Compass Group said it agreed to buy Dutch food services company Vermaat Groep for around 1.5 billion euros ($1.75 billion) including debt, and lifted its guidance for the fiscal year. The U.K.

Sanofi said it agreed to buy U.K. vaccine developer Vicebio for up to $1.6 billion, adding vaccine candidates for respiratory syncytial virus and human metapneumovirus to its pipeline.

Canadian companies face higher costs to purchase goods and services but are limited in raising consumer prices due to competitive pressures and weaker demand, according to quarterly surveys published ...

Net profit for the first six months of 2025 rose to 592 million francs from 588 million francs last year. Analysts had expected 589 million francs. Givaudan said it still expects to exceed the upper ...

The pace of postpaid phone customer defections, or churn, hit 0.97%, up from 0.85% a year ago. The firm increased its ...

Oil futures edged down in a rangebound session, with little in the way of news on the tariff or sanctions fronts moving prices. How China Curbed Its Oil Addiction-and Blunted a U.S. Pressure Point ...

Ken Paxton is looking into a nonprofit foundation linked to Highland Capital Management following a dispute over roughly $270 million in charitable assets involving former Highland CEO James Dondero.